Early Access — free while we kick the tires
EdgarHawk

Cross Shawn

Chief Financial Officer

Officer
1 filing analyzed · 1 company · Latest 2025-12-11

Companies

Company Buys Sells Direction
Pacira BioSciences, Inc. PCRX 0 4 Net selling

Activity

December 2025
medium
Sell
25,000 shares
$626,751
Significance 5/10

CFO Cross Shawn sold 25,000 shares (25.0K shares) for $626,751.44 ($626.8K) across 2 separate sales on 12/09-12/10 at blended average price $25.07

Chief Financial Officer Shawn Cross executed 2 separate sales totaling 25,000 shares for $626,751.44, reducing his holdings by 30.8% from 81,250 to 56,250 shares. The sales occurred at blended average price $25.07, modestly below the current price of $25.73. Pacira trades at a P/E of 51.46 with full-year net income negative, though the latest quarterly net income was $5,432,000 on revenue of $179,516,000. The 30-day stock performance is +6.7%, positioning this sale in a period of recent gains following a 90-day decline of -5.1%.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access